Results 41 - 50 of 1450 : Previous 1 2 3 4 5 6 7 8 9 Next
Look Here for Safe High-Yielders
High-yield companies unlikely to blow up.
3 Things More Important to Pfizer Than Losing Lipitor
It's not like we didn't see it coming.
Why the Street Should Love Merck's Earnings
All cash flow is not created equal.
Do the Shorts Know Something You Don't?
Are these stocks making short work of short sellers?
Winners and Losers of Roche's Avastin Woes
What the FDA giveth, the FDA can taketh away.
Why the Street Should Love Eli Lilly's Earnings
All cash flow is not created equal.
Are Merck's Earnings Better Than They Look?
Don't just count the cash, time it.
Has Eli Lilly Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Teva Pharmaceutical: Dividend Dynamo, or the Next Blowup?
What the numbers tell us.
Here's How Eli Lilly May Be Failing You
Keep your eye on margins.